ClaudeMGalphinMD
Nephrology • Chattanooga, TNAssistant Professor, Clinical Education-Chattanooga, University of Tennessee Health Science Center College of Medicine
Dr. Galphin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
251 N Lyerly St
Suite 100
Chattanooga, TN 37404Phone+1 423-826-8000Fax+1 423-826-8015
Education & Training
Medical College of GeorgiaFellowship, Nephrology, 1983 - 1985- Medical College of GeorgiaResidency, Internal Medicine, 1981 - 1983
Tulane UniversityInternship, Internal Medicine, 1980 - 1981
Medical University of South CarolinaClass of 1980
Certifications & Licensure
TN State Medical License 1997 - 2026
GA State Medical License 1983 - 2025
FL State Medical License 1992 - 2000
AL State Medical License 1995 - 1998
NC State Medical License 1985 - 1998
LA State Medical License 1980 - 1983- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
- Fellow (FACP) American College of Physicians, 1997
Clinical Trials
- Study of Suramin in Subjects With Furosemide-Resistant AKI Start of enrollment: 2020 Nov 13
Roles: Contact
- Efficacy and Safety of Lorundrostat Alone, and in Combination With Dapagliflozin in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria Start of enrollment: 2023 Dec 14
Roles: Contact
Publications & Presentations
PubMed
- Correction to: Bayesian methods: a potential path forward for sepsis trials.George Tomlinson, Ali Al-Khafaji, Steven A Conrad, Faith N F Factora, Debra M Foster
Critical Care. 2024-01-03 - 2 citationsBayesian methods: a potential path forward for sepsis trials.George Tomlinson, Ali Al-Khafaji, Steven A Conrad, Faith N F Factora, Debra M Foster
Critical Care. 2023-11-08 - 16 citationsSafety and Efficacy of Combination ACTHar Gel and Tacrolimus in Treatment-Resistant Focal Segmental Glomerulosclerosis and Membranous Glomerulopathy.James A. Tumlin, Claude Galphin, Raul Santos, Brad H. Rovin
Kidney International Reports. 2017-09-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
